Alterity Therapeutics Limited (ASX:ATH)
Australia · Delayed Price · Currency is AUD 0.0070
-0.0010 (-12.50%)
Jan 30, 2026, 3:59 PM AEST
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of 87 million as of January 29, 2026. Its market cap has increased by 63.53% in one year.
Market Cap
87.00M
Enterprise Value
46.50M
Revenue
5.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since March 28, 2000, Alterity Therapeutics's market cap has increased from 51.51M to 87.00M, an increase of 68.91%. That is a compound annual growth rate of 2.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 87.00M | - |
| Dec 31, 2025 | 87.00M | 104.41% |
| Dec 31, 2024 | 42.56M | 116.97% |
| Dec 29, 2023 | 19.62M | -18.82% |
| Dec 30, 2022 | 24.16M | -52.19% |
| Dec 31, 2021 | 50.54M | -19.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arovella Therapeutics | 105.70M |
| Island Pharmaceuticals | 104.93M |
| Imugene | 102.33M |
| Proteomics International Laboratories | 100.01M |
| LTR Pharma | 99.90M |
| EZZ Life Science Holdings | 86.32M |
| Cynata Therapeutics | 83.41M |
| Radiopharm Theranostics | 81.52M |